At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. A Melbourne hospital quoted up to US$600,000 for CAR-T therapy. He paid less than half that in Shanghai and learned on August 18 that his cancer was in complete remission. CAR-T, or chimeric antigen receptor T-cell therapy, re-engineers a patient’s own immune […] The post Cheaper CAR-T therapy drawing…
Health Minister Arunraj said although successive governments in Tamil Nadu had taken various measures for dengue prevention, it continued to be a major public health concern
Roivant Sciences said Tuesday its inhaled drug candidate has passed a mid-stage test in interstitial lung disease, surpassing Wall Street’s benchmarks for success.
Taylor & Francis is investigating an article in one of its journals after the editors published an editorial about academic freedom that contains multiple fake references and citation errors.
